Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.

Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P, Lombardo C, Aareleid T, Ardanaz E, Bielska-Lasota M, Bolick S, Cress R, Elferink M, Fulton JP, Galceran J, Gózdz S, Hakulinen T, Primic-Zakelj M, Rachtan J, Diba CS, Sánchez MJ, Schymura MJ, Shen T, Tagliabue G, Tumino R, Vercelli M, Wolf HJ, Wu XC, Coleman MP.

BMJ Open. 2013 Sep 10;3(9):e003055. doi: 10.1136/bmjopen-2013-003055. Erratum in: BMJ Open. 2013;3(10):e003055corr1.


A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.


Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmström P, Peignaux K, Primic-Žakelj M, Rachtan J, Safaei Diba C, Sánchez MJ, Schymura MJ, Shen T, Traina A, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP.

Int J Cancer. 2013 Mar 1;132(5):1170-81. doi: 10.1002/ijc.27725. Epub 2012 Sep 18.


Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004078. doi: 10.1002/14651858.CD004078.pub2. Review.


Italian cancer figures - Report 2015: The burden of rare cancers in Italy.

Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, DalMaso L; AIRTUM Working Group.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120.


Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology.

Gatta G, Ciccolallo L, Capocaccia R, Coleman MP, Hakulinen T, Møller H, Berrino F; EUROCARE Working Group.

Eur J Cancer. 2003 Oct;39(15):2214-22.


Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.

Pugh SA, Shinkins B, Fuller A, Mellor J, Mant D, Primrose JN.

Ann Surg. 2016 Jun;263(6):1143-7. doi: 10.1097/SLA.0000000000001351.


Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.

Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.


Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.


Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group.

Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26. Erratum in: Lancet. 2015 Mar 14;385(9972):946.


Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.

Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S, Makuuchi H.

Oncol Rep. 2003 Jul-Aug;10(4):927-34.


Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.

Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sørensen F, Bone J, Jacobsen NO, Sell A, Overgaard J, Bertelsen K, et al.

Br J Cancer. 1992 Jan;65(1):102-7.


Looking at differences in stage and treatment of colorectal cancers across Italy: a EUROCARE-5 high resolution study.

Minicozzi P, Caldarella A, Giacomin A, Ponz de Leon M, Cesaraccio R, Falcini F, Fusco M, Iachetta F, Pellegri C, Tumino R, Capocaccia R, Sant M.

Tumori. 2012 Nov;98(6):671-7. doi: 10.1700/1217.13488.


Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Pahl H, Fateh-Moghadam A.

Anticancer Res. 1997 Jul-Aug;17(4B):2935-8.


Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.

De Quay N, Cerottini JP, Albe X, Saraga E, Givel JC, Caplin S.

Eur J Surg. 1999 Jun;165(6):588-92.


Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.

Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, Watson LF.

Dis Colon Rectum. 1990 Nov;33(11):938-46.


Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I; EUROCARE-4 Working Group.

Lancet Oncol. 2007 Sep;8(9):784-96. Erratum in: Lancet Oncol. 2008 May;9(5):416.


Aspects of survival from colorectal cancer in Denmark.

Iversen LH.

Dan Med J. 2012 Apr;59(4):B4428.


Cancer survival in five continents: a worldwide population-based study (CONCORD).

Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL; CONCORD Working Group.

Lancet Oncol. 2008 Aug;9(8):730-56. doi: 10.1016/S1470-2045(08)70179-7. Epub 2008 Jul 17.


For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC.

Cancer. 1998 Aug 15;83(4):666-72.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk